CClinicalTrials.gg
Status unknownNCT02349035Updated May 13, 2021

Application of Targeted Reinnervation for People With Transradial Amputation

An interventional study of Compare control of multifunction transradial prosthesis and Perform TMR surgery and evaluate transradial TMR pattern recognition control of multifunctional prostheses. in Amputation; Traumatic, Hand, and Wrist and Amputation; Traumatic, Hand, at Wrist Level, sponsored by Shirley Ryan AbilityLab. Status unknown at 3 sites in United States. Open to participants aged 18 Years to 95 Years. Per ClinicalTrials.gov, last updated 2021-05-13.

Sponsored by Shirley Ryan AbilityLab · Not applicable, Interventional, and Basic science

The sponsor has not verified this record recently (last verified May 2021), so the status shown — last known as Active, not recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
10
Allocation
Not applicable
Ages
18 Years to 95 Years
Sex
All
01

Study summary

The purpose of this study is to improve prosthesis control for transradial amputees with combining targeted muscle reinnervation surgery (TMR) and pattern recognition control.

Read the detailed description

Phase 1: Transradial amputees will be asked to come to the Rehabilitation Institute of Chicago, Walter Reed National Military Medical Center or the San Antonio Military Medical Center for initial fitting with a prosthetist for a multifunctional hand system or multifunctional hand and wrist system. The prosthesis system will consist of a custom-made socket and commercially available components. The first visit (up to five days)s involves casting, creating and fitting of a socket that will be used for the study. During the initial and subsequent visits, the subject will be asked asked to practice various control methods using a virtual reality system. EMG data and virtual "games" will be used to practice the control and will provide quantitative data that can be used to assess the various control methods mathematically, without the prosthesis.

Once they receive a socket, they will complete 1-3 days of training to learn how to control the prosthesis with either conventional or pattern recognition control. The prosthetic training days may occur concurrently with the fitting appointment or it may require a separate visit. The subject will return home for the initial 8 week home use trial. They will be asked to use the prosthesis for an average of 2 hours per day across the 8 week home trial period. They will keep a home log of prosthesis use and check in weekly with a therapist to discuss usage and prosthesis performance. They may also be provided with a laptop computer with a camera for Skyping. The laptop can be connected to the prosthesis, and the screen can be viewed remotely. The research team can then continue with remote follow up with more training and problem solving as needed. Directly following the 8 week home trial period, usage data from the prosthesis will be downloaded. The subject will complete 1-3 days of outcomes testing with a therapist. A series of tests will be performed and data recorded of your performance. The subject will then repeat the 1-3 days of training, 8 week home trial period, and 1-3 days of outcomes testing with either the other type of control (i.e. conventional or pattern recognition).

Phase 2: The subject will return to one of the three centers for Targeted Muscle Reinnervation (TMR) surgery. The surgery is an outpatient procedure that will be performed under general anesthesia, consistent with current standard of care. The surgery will involve the transfer of the median nerve to the flexor digitorum superficialis (DFS) muscle and the ulnar nerve will be transferred to the flexor carpi ulnaris (FCU) muscle. Both transfers can be done with a single incision. Alternative target muscles (e.g. the brachioradialis muscle) can be used if trauma interferes with use of the DFS and/or FCU. Some post-operative pain is expected and the subject will be given a prescription for pain medication if needed. Two weeks after the surgery the subject will be asked to start doing exercises to help with muscle recovery. They will return to using the prosthesis from Phase 1 with either conventional or pattern recognition control for 6 months after surgery. Socket adjustments will be made if needed. If they return to using pattern recognition control, their usage and performance data will be tracked during this 6 month period. The subject may be provided with a laptop computer and asked to perform a series of virtual tests. They will receive additional training on how to complete these tests. If the subject returns to using conventional control, they will not be asked to complete the additional tests, nor will the usage or performance data be tracked. Six months after surgery, when reinnervation of the target muscles has been completed, the subject will return to using the prosthesis with pattern recognition control. They will be asked to return to one of the three centers if socket adjustments or a replacement socket is needed. The subject will receive 1-3 days of pattern recognition control training, only this time special attention will be paid to utilizing EMG from target muscles for improved function. Preliminary testing will be done to ensure that they can adequately use the prosthesis. The subject will then take the prosthesis home for a third 8-week home-use trial. The subject will be asked to log daily use of the device, note any issues, and follow up weekly with a therapist. After this home-use trial, the same 1-3 days of comprehensive outcomes testing will be completed and usage data from their prostheses will be downloaded.

Finally, the subject will continue using the prostheses at home for an additional 3-4 months. No usage requirements will be given during this time. At the end of this 3-4 month period (approximately 12 months after surgery), they will have a final round of 1-3 days of testing with the complete toolbox and data from the prosthesis will be downloaded.

The days of prosthesis training and testing may take place at the Rehabilitation Institute of Chicago, Walter Reed National Military Medical Center, or the San Antonio Military Medical Center or near your home. Study coordinators will determine the best location.

02

Conditions studied

  • Amputation; Traumatic, Hand, and Wrist
  • Amputation; Traumatic, Hand, at Wrist Level

Browse trials for

Keywords

  • Transradial amputee
03

In context

Amputation, Traumatic

101 studies on the registry are indexed under Amputation, Traumatic; 14 are open to participants now.

This study's enrollment of 10 is below the median of 13 across 68 interventional studies indexed under Amputation, Traumatic.

Browse Amputation, Traumatic studies →

Lead sponsor

Shirley Ryan AbilityLab is the lead sponsor of 177 studies on the registry; 43 are open to participants now.

Of its 10 completed or terminated interventional studies of FDA-regulated products, 4 (40%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 95 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • A upper limb amputation at the transradial level

Exclusion criteria

Exclusion Criteria:

  • Significant new injury that would prevent use of a prosthesis: The ability to consistently wear a prosthesis and perform activities of daily living and specific performance tasks is necessary to evaluate the relative benefits of the interventions.
  • Cognitive impairment sufficient to adversely affect understanding of or compliance with study requirements, ability to communicate experiences, or ability to give informed consent: The ability to understand and comply with requirements of the study is essential in order for the study to generate useable, reliable data. The ability to obtain relevant user feedback through questionnaires and informal discussion adds significant value to this study.
  • Significant other co morbidity: Any other medical issues or injuries that would preclude completion of the study, use of the prostheses, or that would otherwise prevent acquisition of useable data by researchers
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
10 participants (actual)

Study arms

  • Experimental
    TMR surgery to evaluate pattern recognition control

    Perform Targeted Muscle Reinnervation (TMR) surgery and evaluate transradial TMR pattern recognition control of multifunctional prostheses.

    Device: Compare control of multifunction transradial prosthesis · Procedure: Perform TMR surgery and evaluate transradial TMR pattern recognition control of multifunctional prostheses.

Interventions

  • DeviceCompare control of multifunction transradial prosthesis

    Subjects practice control methods using a VR system. EMG data and virtual games are used and provide data to assess control methods without prosthesis. Subjects are fit with commercially available multifunctional hand system. They receive 1-3 days of training for conventional or pattern recognition control. They return home for an 8 week trial. They use the prosthesis for 2 hours a day across the 8 week trial. They keep a log of use and check with a therapist about usage and performance. After the 8 week trial, data from the prosthesis is downloaded. The subject will complete 1-3 days of outcomes testing. They perform a series of tests and data is recorded. The subject will repeat the 1-3 days of training, 8 week home trial, and 1-3 days of outcomes testing with either type of control.

  • ProcedurePerform TMR surgery and evaluate transradial TMR pattern recognition control of multifunctional prostheses.

    Subject has Targeted Muscle Reinnervation surgery. The surgery transfers median nerve to flexor digitorum superficialis muscle and ulnar nerve to flexor carpi ulnaris muscle. Two weeks after surgery, exercises start for muscle recovery. Then return to prosthesis from Phase 1 for 6 months. If they have pattern recognition control, usage and performance will be tracked for 6 months. If they return to conventional control, they will not complete tests, track usage, or performance. Six months after surgery, they return to pattern recognition control. Receive 1-3 days of training. Take prosthesis home for 8 week trial. Log use of device, note issues, and follow up with therapist. After home trial, 1-3 days of outcomes testing are completed and usage data downloaded. Continue using their prostheses for an additional 3-4 months. At 12 months after surgery, a final round of 1-3 days of testing and data are downloaded.

06

What researchers measure

Primary outcomes

  1. Improve pattern recognition control of multifunction prostheses for transradial amputees.

    Improved control of prosthesis as seen through functional use improvements.

    Time frame: 15 months from initial enrollment

Secondary outcomes

  1. Modified Box and Blocks

    Timed task to assess prosthetic control.

    Time frame: At 2 and 4 months pre-op; At 6 and 10 months post-op

  2. Clothespin Relocation Test

    Timed task to assess prosthetic control.

    Time frame: At 2 and 4 months pre-op; At 6 and 10 months post-op

  3. ACMC

    Assessment of capacity for myoelectric prosthetic control

    Time frame: At 2 and 4 months pre-op; At 6 and 10 months post-op

  4. Jebsen Test of Hand Function

    7 part timed diagnostic test to determine the level of hand function.

    Time frame: At 2 and 4 months pre-op; At 6 and 10 months post-op

  5. Southampton Hand Assessment Procedure (SHAP)

    The test consists of the manipulation of a series of both lightweight and heavyweight abstract objects. The procedure is designed to provide a score of functionality.

    Time frame: At 2 and 4 months pre-op; At 6 and 10 months post-op

  6. OPUS-UEFS

    An instrument that evaluates the activity limitations, quality of life, and patient satisfaction with services and devices.

    Time frame: At 2 and 4 months pre-op; At 6 and 10 months post-op

  7. Activities Measure for Upper Limb Amputees (AM-ULA)

    A clinician rated measure of an upper limb amputee's performance of daily functional activities using a prosthesis.

    Time frame: At 2 and 4 months pre-op; At 6 and 10 months post-op

  8. TAC TEST/ Motion Test

    Virtual reality testing of classification accuracy, motion completion rate, motion completion time and path efficiency.

    Time frame: At 2 and 4 months pre-op; At 6 and 10 months post-op

  9. PSFS

    Used to assess functional ability to complete specific activities

    Time frame: At 2 and 4 months pre-op; At 6 and 10 months post-op

07

Study locations

3 sites
  • Rehabilitation Institute of Chicago
    Chicago, Illinois 60611, United States
  • Walter Reed National Military Medical Center
    Bethesda, Maryland 20889, United States
  • San Antonio Military Medical Center
    Fort Sam Houston, Texas 78234, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 13, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02349035
Lead sponsor
Shirley Ryan AbilityLab
Collaborators
Walter Reed National Military Medical Center, San Antonio Military Medical Center, Northwestern University, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Responsible party
Todd Kuiken (Director, Center for Bionic Medicine, Shirley Ryan AbilityLab) — Principal investigator
First posted
Jan 28, 2015
Start date
Dec 2014
Primary completion
Dec 2020
Completion
Jan 2022 (estimated)
Last update
May 13, 2021

Study contacts

Todd A Kuiken, MD, PhD
principal investigator · Shirley Ryan AbilityLab

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in May 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion